Abstract
Skeletal X-ray survey is the established method of diagnosis in patients with multiple myeloma; however, whole-body magnetic resonance imaging (wb-MRI) has become an important additional tool. The aim of this study was to compare the different patterns of infiltration on conventional X-ray examinations (X-ray survey) with findings from wb-MRI to subsequently determine the influence of wb-MRI on therapy changes. In 60 patients with a mean age of 65.1 ± 11.7 years, wb-MRI examinations were correlated with a recent X-ray survey. The results were independently assessed by two radiologists and the patterns of infiltration were described in both modalities. Subsequently, the disease was staged according to Salmon and Durie and Salmon and Durie PLUS. Additionally, the influence of MRI on potential changes in therapy was assessed using a three-range Likert-type scale. In all, 480 skeletal regions were compared. In 183 skeletal regions, an increased degree of infiltration was identified on wb-MRI. Significant differences (p < 0.05) between the modalities could be found in the thorax, spine, pelvis, and both lower extremities. Based on wb-MRI, tumor stage was upgraded in 19 of the 60 patients using the Durie and Salmon PLUS classification. In ten out of these 19 patients (42%), the wb-MRI result was essential for making the decision to initiate further therapy due to the degree of infiltration, extramedullary tumor extension, and/or further risk of fracture. Whole-body MRI provides a more detailed assessment of the pattern of bone marrow infiltration and strongly influences therapeutic strategies.
Similar content being viewed by others
References
Kelly JJ (1999) Neuropathies of monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North 13(6):1203–1210
Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M (2002) Magnetic resonance imaging as a supplement for the clinical staging system of Durie und Salmon? Cancer 95(6):1334–1345
Durie BG (2006) The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 42(11):1539–1543
Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, Child JA, Comenzo R, Djulbegovic B, Fantl D, Gahrton G, Harousseau JL, Hungria V, Joshua D, Ludwig H, Mehta J, Morales AR, Morgan G, Nouel A, Oken M, Powles R, Roodman D, San Miguel J, Shimizu K, Singhal S, Sirohi B, Sonneveld P, Tricot G, Van Ness B, Scientific Advisors of the International Myeloma Foundation (2003) Myeloma management guidelines, a consensus report from the Scientific Advisors of International Myeloma Foundation. Hematol J 4(6):379–398
Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842–854
Baur A, Stäbler A, Bartl R, Lamerz R, Reiser M (1996) Infiltration patterns of plasmacytomas in magnetic resonance tomography. RoFo 164(6):457–463
Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55(1):56–63
Eustace S, Tello R, Decarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole body turbo STIR MR imaging and planar 99Tc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169(6):1655–1661
Lecouvet FE, Vande Berg BC, Michaux L, Malghem J, Maldague BE, Jamart J, Ferrant A, Michaux JL (1998) Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 209(3):653–660
Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE, Jamart J, Ferrant A, Vande Berg BC (1997) Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 204(1):201–205
Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J, Brouet JC, Fermand JP (1999) Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol 104:723–729
Steinborn M, Tilling R, Heuck A, Brügel M, Gauger L, Reiser M (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129
Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M (2004) Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histologic findings. Cancer 101:2599–2604
Lecouvet FE, Malghem JL, Michaux L, Maldague B, Ferrant A, Michaux JL, Vande Berg BC (1999) Skeletal survey in advanced multiple myeloma: radiography versus MRI survey. Br J Haematol 106(1):35–39
Ghanem N, Altehöffer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumor of axial skeleton. Eur J Radiol 43(3):256–261
Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55(1):41–55
Schäfer FJ, Fischmann A, Lichy M, Vollmar J, Fenchel M, Claussen CD, Schlemmer HP (2004) Oncologic screening with whole-body MRI: possibilities and limitations. Radiologe 44:854–863
Ghanem N, Lohrmann C, Engelhard M, Pache G, Uhl M, Saueressig U, Kotter E, Langer M (2006) Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to radiologic skeletal survey. Eur Radiol 16(5):1005–1014
Bowker AH (1948) A test for symmetry in contingency tables. J Am Stat Assoc 43:572–574
Ludwig H, Frühwald F, Tscholakoff D, Rasoul S, Neuhold A, Fritz E (1987) Magnetic resonance imaging of the spine in multiple myeloma. Lancet 2(8555):364–366
Frühwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek PC (1988) MRI of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23(3):193–199
Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F (2001) Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 28(6):543–550
Vande Berg BC, Lecouvet FE, Michaux L, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1996) Stage I multiple myeloma: value of MRI in the bone marrow in the determination of prognosis. Radiology 201(1):243–246
Vande Berg BC, Michaux L, Lecouvet FE, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1997) Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 202(1):247–251
Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI, Alexanian R (1995) Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 13(1):251–256
Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ (2007) Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 25(9):1121–1128
Antoch G, Vogt FM, Bockisch A, Rühm SG (2004) Whole-body tumor staging: MRI or FDG–PET/CT? Radiologe 44(9):882–888
Baur A, Stäbler A, Steinborn M, Schnarkowski P, Pistitsch C, Lamerz R, Bartl R, Reiser M (1998) Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns. RoFo 168(4):323–329
Moulopoulos LA, Dimopoulos MA (1997) Magnetic resonance imaging of bone marrow in haematologic malignancies. Blood 90(6):2127–2147
Baur-Melnyk A, Reiser M (2004) Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography. Radiologe 44(9):874–881
Rahmouni A, Divine M, Mathieu D, Golli M, Dao TH, Jazaerli N, Anglade MC, Reyes F, VasiIe N (1993) Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR-imaging. AJR Am J Roentgenol 160(5):1049–1052
Wasser K, Möhler T, Nosas-Garcia S, Rehm C, Bartl R, Goldschmidt JH, Düber C, Kauczor HU, Delorme S (2005) Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. RoFo 177(8):1116–1122
Buss DH, Prichard RW, Hartz JW, Cooper MR, Feigin GA (1986) Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. Arch Pathol Lab Med 110(1):30–33
Schmidt GP, Baur A, Stäbler A, Schönberg SO, Steinborn M, Baltin V, Reiser MF (2005) Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results. RoFo 177(5):745–750
Rahmouni A, Divine M, Mathieu D, Golli M, Hajoun C, Dao T, Anglade MC, Reyes F, Vasile N (1993) MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 160(5):1053–1057
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dinter, D.J., Neff, W.K., Klaus, J. et al. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 88, 457–464 (2009). https://doi.org/10.1007/s00277-008-0621-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0621-6